ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,983, issued on July 7, was assigned to Sutro Biopharma. Inc. (South San Francisco, Calif.).

"E. coli strains for producing full-length antibodies" was invented by Daniel Groff (Alameda, Calif.) and Jeffrey Hanson (Oakland, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides methods and compositions related to producing full-length antibodies in E. coli having an oxidative cytoplasm, which is helpful for maintaining the three-dimensional structure and stability of proteins having disulfide bonds. The E. coli is used to produce full length antibody in high yield."

The patent was filed on June 6, 2025, under Application No. 1...